日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Evaluation of the international Ki67 working group cut point recommendations for early breast cancer: comparison with 21-gene assay results in a large integrated health care system

对国际 Ki67 工作组早期乳腺癌临界值建议的评估：与大型综合医疗保健系统中 21 基因检测结果的比较

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-023-07118-4
Shim, Veronica C; Baker, Robin J; Jing, Wen; Puentes, Roisin; Agersborg, Sally S; Lee, Thomas K; GoreaI, Wamda; Achacoso, Ninah; Lee, Catherine; Villasenor, Marvella; Lin, Amy; Kapali, Malathy; Habel, Laurel A
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Expanding the clinical utility of liquid biopsy by using liquid transcriptome and artificial intelligence

利用液体转录组和人工智能拓展液体活检的临床应用

期刊:
影响因子:
doi:10.1016/j.jlb.2024.100270
Albitar, Maher; Charifa, Ahmad; Agersborg, Sally; Pecora, Andrew; Ip, Andrew; Goy, Andre
发表日期：2024
文献求助 收藏

Liquid biopsy for evaluating mutations and chromosomal aberrations in cerebrospinal fluid from patients with primary or metastatic CNS tumors

液体活检用于评估原发性或转移性中枢神经系统肿瘤患者脑脊液中的突变和染色体畸变

期刊:
影响因子:
doi:10.1016/j.jlb.2024.100281
Charifa, Ahmad; Agersborg, Sally; Mohtashamian, Arash; Ip, Andrew; Goy, Andre; Albitar, Maher
肿瘤
肿瘤免疫
神经科学
发表日期：2024
文献求助 收藏

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification

HER2扩增结果不明确的乳腺癌的免疫组织化学和替代性FISH检测

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-018-4755-5
Agersborg, Sally; Mixon, Christopher; Nguyen, Thanh; Aithal, Sramila; Sudarsanam, Sucha; Blocker, Forrest; Weiss, Lawrence; Gasparini, Robert; Jiang, Shiping; Chen, Wayne; Hess, Gregory; Albitar, Maher
肿瘤
IHC
HER2
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2018
文献求助 收藏

Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer

MET基因扩增和TP53突变与非小细胞肺癌中PD-L1表达的相关性

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.24455
Albitar, Maher; Sudarsanam, Sucha; Ma, Wanlong; Jiang, Shiping; Chen, Wayne; Funari, Vincent; Blocker, Forrest; Agersborg, Sally
肺癌
肿瘤
肿瘤免疫
PD-L1
P53
细胞生物学
MET
发表日期：2018
文献求助 收藏

Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits

与FDA批准的试剂盒相比，使用新一代测序技术在检测BRAF、KRAS和EGFR突变方面取得了显著改进

期刊:Molecular Diagnosis & Therapy
影响因子:4.4
doi:10.1007/s40291-017-0290-z
Ma, Wanlong; Brodie, Steven; Agersborg, Sally; Funari, Vincent A; Albitar, Maher
EGF
BRAF
Sequencing
EGFR
RAS
发表日期：2017
文献求助 收藏

BCR-JAK2 fusion as a result of a translocation (9;22)(p24;q11.2) in a patient with CML-like myeloproliferative disease

在患有慢性粒细胞白血病样骨髓增生性疾病的患者中，由于易位 (9;22)(p24;q11.2) 导致 BCR-JAK2 融合。

期刊:Molecular Cytogenetics
影响因子:1.4
doi:10.1186/1755-8166-5-23
Elnaggar, Mohamed M; Agersborg, Sally; Sahoo, Trilochan; Girgin, Ati; Ma, Wanlong; Rakkhit, Ronjay; Zorrilla, Isabel; Leal, Alexis
JAK/STAT
白血病
BCR
细胞生物学
JAK2
粒细胞
发表日期：2012
文献求助 收藏

The pharmacology of penamecillin

培那西林的药理学

期刊:
影响因子:
doi:10.1111/j.1476-5381.1966.tb01844.x
Agersborg, H P; Batchelor, A; Cambridge, G W; Rule, A W
发表日期：1966
文献求助 收藏